This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Quetiapine: Another Drug With Potential for Misuse? A Case Report

Thomas Paparrigopoulos, MD, PhD; Dimitris Karaiskos, MD; and John Liappas, MD, PhD

Published: January 15, 2008

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: The introduction of atypical antipsychotics in the early1990s opened a new era in the management of schizophreniaand bipolar disorders.1 Although not officially approved, someof these agents have lately been tried for the adjunctive treatmentof substance abuse.2-5Several studies suggest that quetiapine may reduce cravingin alcohol-dependent individuals.3,5-7‘ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 69

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...